| Registry | NCT06628167, acronym LCS II |
|---|
| Status | Completed |
|---|
| Phase | Not applicable |
|---|
| Study type | Interventional; non randomized, parallel, masking: none, health services research |
|---|
| Enrollment | 252 (Actual) |
|---|
| Sponsor | Abramson Cancer Center at Penn Medicine (Other); collaborators: University of Pennsylvania |
|---|
| Conditions | Lung Cancer |
|---|
| Interventions | Transportation, Scheduling (Behavioral) |
|---|
| Dates | start 2024-10-01, primary completion 2026-02-01, completion 2026-02-01, first posted 2024-10-04, last updated 2026-03-24 |
|---|
| Locations | 1 site in United States |
|---|
Related Papers Related Patents Related Grants Related Experts
All trials for Lung Cancer All trials of Transportation All trials of Scheduling
-Summary
This is a West Philadelphia based community project to improve adherence to lung cancer screening. The overall objective of this project is to demonstrate the impact of a community support program (CSP) on improve adherence to LCS follow-up guidelines in an urban environment. The study will target individuals in the Penn Medicine healthcare system residing in Philadelphia with an upcoming or missed follow-up screening or orders placed but who have not yet scheduled their screenings by offering free transportation coordination to and from the appointment. The study team will also offer to connect those with placed but unscheduled low dose CT orders to connect with Penn Medicine's scheduling staff.
Expand all sections · Collapse all
+Arms and interventions
| Arm | Type | Interventions | Description |
|---|
| West Philadelphia | Experimental | Behavioral: Transportation; Behavioral: Scheduling | Eligible patient population lives in West Philadelphia |
| Southwest Philadelphia | No intervention | | Eligible patient population lives in Southwest Philadelphia |
- Transportation (Behavioral): Participants with ordered low dose CT and participants with scheduled low dose CT are offered free transportation to and from appointment. Participants with ordered low dose CT are also offered assistance in connecting with scheduling staff.
- Scheduling (Behavioral): Participants with ordered low dose CT are offered assistance in connecting with scheduling staff.
+Outcome measures
Primary outcomes
- Scheduled Lung Cancer Screening Appointments Attended by Participants [12 months]: The Primary Outcome measures appointment attendance across three groups: West Philadelphia CSP Participants (eligible West Philadelphia residents who opted into the CSP), West Philadelphia Non CSP Participants (eligible West Philadelphia residents who did not opt into the CSP), and Southwest Philadelphia Residents (patients who did not receive an option to participate in the CSP).
Secondary outcomes
- CSP Enrollment [12 months]: The Secondary outcome is a measurement of the how many eligible participants (West Philadelphia residents) chose to opt into the CSP (as opposed to eligible participants who did not).
+Eligibility
Sex: All, ages: 18 Years to 89 Years, accepts healthy volunteers
Inclusion Criteria:
* Upcoming or missed low dose CT for lung cancer screening
* Philadelphia resident
Exclusion Criteria:
* Lives outside Philadelphia city limits
+Posted results
Participant flow
| Milestone | 1. West Philadelphia CSP Participants | 2. West Philadelphia Non CSP Participants | 3. Southwest Philadelphia Residents |
|---|
| Started | 34 | 105 | 113 |
| Completed | 34 | 105 | 113 |
| Not completed | 0 | 0 | 0 |
Outcome results
- Scheduled Lung Cancer Screening Appointments Attended by Participants (Primary), Count of participants, Participants: 1. West Philadelphia CSP Participants 21; 2. West Philadelphia Non CSP Participants 65; 3. Southwest Philadelphia Residents 59
- CSP Enrollment (Secondary), Count of participants, Participants: West Philadelphia Residents 34
Adverse events
| Arm | Deaths | Serious adverse events | Other adverse events |
|---|
| 1. West Philadelphia CSP Participants | 0 | 0 | 0 |
| 2. West Philadelphia Non CSP Participants | 0 | 0 | 0 |
| 3. Southwest Philadelphia Residents | 0 | 0 | 0 |
+Locations (1)
| Facility | City | Country | Status |
|---|
| Univeristy of Pennsylvania | Philadelphia, Pennsylvania | United States | |
+Study documents
+Investigators
- Farouk Dako, MD, Principal investigator, farouk.dako@pennmedicine.upenn.edu